We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares
NBP

29 hedge funds and large institutions have $7.41M invested in NovaBridge Biosciences American Depositary Shares in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

45% more call options, than puts

Call options by funds: $16K | Put options by funds: $11K

4% more funds holding

Funds holding: 28 → 29 (+1)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

1.57% less ownership

Funds ownership: 6.4% → 4.83% (-1.6%)

27% less capital invested

Capital invested by funds: $10.1M → $7.41M (-$2.72M)

Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
3
Calls
$16K
Puts
$11K
Net Calls
+$5K
Net Calls Change
+$17K

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$459K
2
SG Americas Securities
SG Americas Securities
New York
+$329K
3
UBS Group
UBS Group
Switzerland
+$205K
4
GSC
Ground Swell Capital
South Carolina
+$60.5K
5
HSA
HBK Sorce Advisory
Pennsylvania
+$43.7K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$3.33M
2
CF
Cantor Fitzgerald
New York
-$119K
3
Two Sigma Investments
Two Sigma Investments
New York
-$114K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$64.2K
5
Millennium Management
Millennium Management
New York
-$34.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
1
HHLR Advisors
Cayman Islands
$4.93M – – –
SG Americas Securities
2
SG Americas Securities
New York
$677K +$329K +346,179 +73%
SCM
3
Stonepine Capital Management
Oregon
$398K +$459K +483,647 New
Two Sigma Advisers
4
Two Sigma Advisers
New York
$299K -$64.2K -67,600 -16%
UBS Group
5
UBS Group
Switzerland
$262K +$205K +215,492 +209%
Two Sigma Investments
6
Two Sigma Investments
New York
$173K -$114K -119,840 -36%
Aberdeen Group
7
Aberdeen Group
United Kingdom
$134K – – –
BNP Paribas Financial Markets
8
BNP Paribas Financial Markets
France
$99.6K +$11.1K +11,700 +11%
AIMCA
9
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$61.6K – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$52.6K – – –
GSC
11
Ground Swell Capital
South Carolina
$52.5K +$60.5K +63,730 New
Millennium Management
12
Millennium Management
New York
$50.7K -$34.5K -36,271 -37%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$48.1K – – –
HSA
14
HBK Sorce Advisory
Pennsylvania
$37.9K +$43.7K +46,060 New
Morgan Stanley
15
Morgan Stanley
New York
$28.7K -$3.33M -3,508,567 -99%
Barclays
16
Barclays
United Kingdom
$25K – – –
Mariner
17
Mariner
Kansas
$23.7K – – –
Geode Capital Management
18
Geode Capital Management
Massachusetts
$18.2K – – –
HF
19
HRT Financial
New York
$13K +$2.76K +2,904 +22%
Goldman Sachs
20
Goldman Sachs
New York
$8.8K – – –
FCH
21
Freestone Capital Holdings
Washington
$8.24K – – –
JP Morgan Chase
22
JP Morgan Chase
New York
$4.12K +$4.75K +5,000 New
Simplex Trading
23
Simplex Trading
Illinois
$2K +$2.29K +2,415 +297%
SS
24
SBI Securities
Japan
$746 – – –
Bank of America
25
Bank of America
North Carolina
$466 – – –
1
2

NBP Hedge Fund Activity: Q1 2025 in Review

29 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2025, worth a combined $7.41M — down 27% from $10.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NBP positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $459K. The largest seller was Morgan Stanley, cutting an estimated $3.33M.

  • 29 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2025, up from 28 in Q4 2024.
  • Funds reported $7.41M of NovaBridge Biosciences American Depositary Shares stock for Q1 2025, down 27% quarter-over-quarter.
  • 5 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2025 and 3 closed out, a net change of +2 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2025 was Stonepine Capital Management, an estimated $459K added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2025 was Morgan Stanley, an estimated $3.33M sold.

Based on aggregated 13F filings for Q1 2025.